Shopping Cart
- Remove All
Your shopping cart is currently empty
Laduviglusib [CHIR 99021; CHIR99021; CHIR-99021; CT99021; CT 99021; CT-99021] is a potent, selective small-molecule inhibitor of glycogen synthase kinase 3 (GSK-3) with the formula C22H18ClN5O. It is used extensively in biomedical research to explore the role of GSK-3 in various cellular processes and diseases.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks |
| Description | Laduviglusib [CHIR 99021; CHIR99021; CHIR-99021; CT99021; CT 99021; CT-99021] is a potent, selective small-molecule inhibitor of glycogen synthase kinase 3 (GSK-3) with the formula C22H18ClN5O. It is used extensively in biomedical research to explore the role of GSK-3 in various cellular processes and diseases. |
| Synonyms | CT99021 dihydrochloride, CHIR-99021 dihydrochloride |
| Molecular Weight | 538.26 |
| Formula | C22H20Cl4N8 |
| Cas No. | 2109414-84-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.